Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of combined T and B cell immunodeficiency (CID) characterized by severe and persistent cytomegalovirus (CMV) infection and autoimmune cytopenia.
RAG1 function has not been fully characterized.
Combined immunodeficiency due to partial RAG1 deficiency is associated with mutations in the RAG1 gene on chromosome 11.
Genetic testing for RAG1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for combined immunodeficiency due to partial RAG1 deficiency.
3 publications have been identified in PubMed for combined immunodeficiency due to partial RAG1 deficiency. Research spans Case Report / Case Series (33%), Clinical Trial Publication (33%), and Epidemiology / Natural History (33%).
Wang C (2025). [PMID: 40697949](https://pubmed.ncbi.nlm.nih.gov/40697949/). *The journal of allergy and clinical immunology. Global*. [Epidemiology / Natural History]
Meng X (2025). [PMID: 40829114](https://pubmed.ncbi.nlm.nih.gov/40829114/). *Blood advances*. [Clinical Trial Publication]
Chen X (2024). [PMID: 39720732](https://pubmed.ncbi.nlm.nih.gov/39720732/). *Front Immunol*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about combined immunodeficiency due to partial RAG1 deficiency